| Literature DB >> 33842764 |
Cui Guo1,2,3,4,5, Pei Wang6, Xiaoyan Pang1,3,4,5, Xiuping Lin1,7,3,4,5, Shengrong Liao1,7,3,4,5, Bin Yang1,7,3,4,5, Xuefeng Zhou1,7,3,4,5, Junfeng Wang1,7,3,4,5, Yonghong Liu1,7,2,3,4,5.
Abstract
In devotion to investigating structurally novel and biologically active marine natural products, a dimer of a zinc complex, dizinchydroxyneoaspergillin (1), aspernones A-E (2-6), five cyclopentenone derivatives together with known polyketides (7-10), and neoaspergillic acid analogues (11-14) were isolated from the sponge-associated fungus Aspergillus ochraceopetaliformis SCSIO 41018. Their structures were elucidated on the basis of spectroscopic analysis, electronic circular dichroism (ECD) analysis, and X-ray diffraction. Dizinchydroxyneoaspergillin (1) displayed significant bactericide effects toward methicillin-resistant Staphyloccocus aureus, Staphyloccocus aureus, Enterococcus faecalis, Acinetobacter baumannii, and Klebsiella pneumonia with MIC values of 0.45-7.8 μg/mL and moderate in vitro cytotoxic activities against the K562, BEL-7402, and SGC-7901 cell lines with IC50 values of 12.88 ± 0.14, 15.83 ± 0.23, and 15.08 ± 0.62 μM, respectively. This is the first time to report the dimer of the zinc complex of hydroxyneoaspergillic acid conjunction at Zn-N-4 by a coordination bond. Additionally, compound 1 displayed significant antibacterial and cytotoxic activities, which would be a promising drug lead and could attract much attention from both chemists and pharmacists.Entities:
Year: 2021 PMID: 33842764 PMCID: PMC8028006 DOI: 10.1021/acsomega.0c06218
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Structures of compounds 1–14 from Aspergillus ochraceopetaliformis SCSIO 41018.
1H and 13C NMR Data for 1 and 6 (TMS, δ ppm)a,b
| no. | no. | ||||
|---|---|---|---|---|---|
| δC | δH ( | δC | δH ( | ||
| 2 | 154.9 C | 1 | 199.9 C | ||
| 3 | 146.7 C | 2 | 73.3 C | ||
| 5 | 125.2 CH | 7.55, s | 3 | 202.1 C | |
| 6 | 141.9 C | 4 | 134.8 C | ||
| 1′ | 70.2 CH | 4.81, d (2.9) | 5 | 165.8 C | |
| 2′ | 30.7 CH | 2.09–2.15, m | 6 | 7.0 CH3 | 1.93, s |
| 3′ | 19.6 CH3 | 0.92, d (6.4) | 7 | 20.3 CH3 | 1.32, s |
| 4′ | 16.3 CH3 | 0.75, d (6.6) | 8 | 60.3 CH3 | 4.33, s |
| 1″ | 41.4 CH2 | 2.55–2.62, m | |||
| 2″ | 26.7 CH | 2.09–2.15, m | |||
| 3″ | 22.5 CH3 | 0.85, d (6.4) | |||
| 4″ | 22.5 CH3 | 0.85, d (6.4) | |||
1H and 13C NMR data of 1 recorded at 500 MHz and 125 MHz in DMSO-d6, respectively.
1H and 13C NMR data of 2 recorded at 700 MHz and 175 MHz in CDCl3, respectively.
Figure 2Key 1H–1H COSY (bold) and HMBC (arrows) correlations of 1–6.
1H and 13C NMR Data for 2, 3, 4, and 5 (700, 175 MHz, TMS, δ ppm)a,b
| no. | δC | δH ( | δC | δH ( | δC | δH ( | δC | δH ( |
|---|---|---|---|---|---|---|---|---|
| 1 | 198.4 C | 201.7 C | 204.0 C | 201.6 C | ||||
| 2 | 117.5 C | 116.5 C | 120.8 C | 115.6 C | ||||
| 3 | 188.3 C | 183.0 C | 190.0 C | 179.8 C | ||||
| 4 | 36.3 CH2 | 2.63, d (18.0) | 31.7 CH2 | 2.83, dq (17.5, 1.7) | 31.8 CH2 | 3.06, d (18.4) | 73.6 CH | 5.01, q (1.4) |
| 2.48, d (18.0) | 2.60, dq (17.5, 1.7) | 3.06, d (18.4) | ||||||
| 5 | 84.3 C | 83.0 C | 84.4 C | 86.3 C | ||||
| 6 | 70.8 C | 5.20, q (6.3) | 70.3 CH | 5.20, q (6.3) | 71.7 CH | 5.12, q (6.4) | ||
| 7 | 15.3 CH3 | 1.26, d (6.3) | 14.8 CH3 | 1.31, d (6.3) | 14.9 CH3 | 1.29, d (6.4) | ||
| 1′ | 176.4 C | 175.0 C | 176.5 C | 177.4 C | ||||
| 2′ | 42.7 CH | 2.17–2.22, m | 41.3 CH | 2.21–2.26, m | 42.4 CH | 2.21–2.26, m | 42.1 CH | 2.38–2.41, m |
| 3′ | 27.6 CH2 | 1.44–1.51, m | 26.7 CH2 | 1.51–1.58, m | 27.6 CH2 | 1.49–1.53, m | 27.8 CH2 | 1.65–1.68, m |
| 1.33–1.39, m | 1.34–1.40, m | 1.36–1.40, m | 1.47–1.51, m | |||||
| 4′ | 11.9 CH3 | 0.82, t (7.4) | 11.7 CH3 | 0.85, t (7.4) | 11.9 CH3 | 0.84, t (7.4) | 11.9 CH3 | 0.97, t (7.4) |
| 5′ | 17.2 CH3 | 0.99, d (7.0) | 16.8 CH3 | 1.03, d (7.0) | 17.0 CH3 | 1.01, d (7.0) | 16.8 CH3 | 1.14, d (7.0) |
| 5-OMe/Me | 51.3 CH3 | 3.14, s | 52.0 CH3 | 3.23, s | 52.0 CH3 | 3.20, s | 19.5 CH3 | 1.32, s |
| 2-Me/CH2OH | 5.5 CH3 | 1.58, s | 6.0 CH3 | 1.63, s | 51.6 CH2 | 4.14, d (1.96) | 6.1 CH3 | 1.69, d (1.5) |
| 3-OH/OMe | 57.1 CH3 | 4.01, s | 58.8 CH3 | 4.17, s | 59.2 CH3 | 4.18, s | ||
Recorded in CD3OD.
Recorded in CDCl3.
Figure 3ORTEP drawings of compounds 1 and 2.
Figure 4Comparison between calculated and experimental ECD spectra of 3–6.
Inhibitory Effects of Tested Compounds against Pathogenic Bacteria
| pathogenic
bacteria (MIC, μg/mL) | ||||||
|---|---|---|---|---|---|---|
| comp. | MRSA | |||||
| 7.8 | 7.8 | 0.9 | 0.45 | 62.5 | 7.8 | |
| 3.9 | 3.9 | 0.9 | 0.45 | 125 | 3.9 | |
| ampicillin | 0.65 | 0.325 | 0.04 | — | — | — |
| gentamicin | — | — | — | 0.33 | 1.25 | 0.16 |